Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AACR, absolutely, ACA, activist, Addendum, AI, algorithm, allorejection, Anacor, ansegedleucel, arbitration, Arbor, artificial, automated, autoreactive, bacterial, belief, belzutifan, BioMimetic, Biotechology, box, broadest, Bruton, BTKi, Cabaletta, CARGO, Carlo, Cartesian, CASL, Catalent, CCSP, CDMO, cemacabtagene, chart, Chase, chemoimmunotherapy, chosen, circumvention, CISSP, CLL, closure, Coast, Columbia, comment, condensed, Connecticut, Correctly, count, CTR, degradation, DEIB, deprioritize, deprioritized, depth, dollar, double, Draft, Earl, EEA, EFS, elaborate, embed, ensued, essence, exemplifying, experimental, fake, filer, Foresight, forum, frontline, gather, gathering, Geoffrey, GMP, Goldman, Goodrich, Gotshal, groundbreaking, grounded, headache, hour, hyperinflammation, hyperinflammatory, imparting, Imugene, inappropriately, ineffective, inflammatory, intelligence, Interagency, invasion, Israel, JPMorgan, Kallyope, Kiverdi, Kyverna, lawfully, leaked, leapfrog, lending, LetterOne, likewise, logistical, mAb, mistakenly, Monte, monthly, monumental, noncash, nonexclusive, Nordisk, Northwestern, novo, NV, obscure, opportunistic, OPX, organizational, outline, outlining, overcharged, paired, paragraph, Parker, pathogenic, pausing, pendency, penetration, Perrigo, PIPEDA, PMA, pose, predicate, premarket, pro, provincial, psychological, purified, QSR, radiographically, radiological, rapporteur, rata, reassessment, receivership, redefine, relocate, rental, repositioning, Republic, respiratory, retrain, Rosati, route, rumored, runway, Russian, secretary, seized, sending, shortly, Signature, Silicon, Silvergate, simpler, simply, simulation, Sonsini, sought, Spinal, sterling, straightforward, sublet, subscribing, SVB, swept, thirdparty, tighten, tighter, Timothy, tivozanib, TRAC, trail, transgene, Tricida, Tulsa, unaudited, undermine, underperformance, understatement, underway, Undetected, uninsured, Unremediated, unscheduled, upregulate, upregulated, uptake, Utah, vacated, Valley, wage, watch, Weil, West, wholly, Wilson
Removed:
Alison, AML, AMP, applying, apportioned, ArsenalBio, attestation, bear, behavior, capped, cleavage, cleave, CMO, conclusion, confer, constitutive, contact, contracting, curtailed, cut, cutting, cytotoxic, Darzalex, DEI, differentiated, diffuse, directing, dispensed, displaced, disposing, distancing, distinguished, DLBCL, elderly, electrical, elementary, Empliciti, encouraging, Ernst, escape, eventually, exploratory, Farydak, FCA, fidelity, fight, forced, formation, formula, frontier, fusing, fusion, genomic, gradually, grow, halting, hematology, hired, histocompatibility, homogeneity, hosting, impacting, inactivating, infant, inhibiting, intact, interval, interview, isolated, jointly, Kuur, localize, mainstay, mediated, microenvironment, migratory, mimic, Mimicking, modifying, modulation, Moving, mRNA, multiplied, neuroendocrine, Ninlaro, nirogacestat, nondeductible, nuclease, older, overcoming, overnight, parameter, peptide, pertain, phasing, philosophy, pioneered, plasma, polypeptide, Pomalyst, poverty, productivity, proliferating, proliferative, propagated, proteasome, quarantine, recombination, Referral, referring, reject, rendered, renewable, resistant, Revlimid, sample, scaling, Seattle, Selectivity, separating, sequester, shelter, shorter, Silverback, suppressive, susceptible, tailored, TALE, targetable, telecommunication, termed, Tessa, Thalomid, thawing, thereon, threatening, today, transcription, transformed, translated, translational, travel, uncontrolled, underserved, UNIVERSAL, unjustified, unqualified, unwanted, utility, Velcade, version, VGPR, virally, warranted, withdrawing, Xpovio, York
Filing tables
Filing exhibits
Related press release
Associated ALLO transcripts
ALLO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
(1)Registration Statements (Forms S-8 Nos. 333-227965, 333-230164, 333-236701, 333-253530, 333-262923 and 333-270098) pertaining to the Amended and Restated 2018 Equity Incentive Plan and 2018 Employee Stock Purchase Plan of Allogene Therapeutics, Inc., and
(2)Registration Statement (Form S-3 No. 333-268117) of Allogene Therapeutics, Inc.;
of our report dated March 14, 2024, with respect to the consolidated financial statements of Allogene Therapeutics, Inc. included in this Annual Report (Form 10-K) of Allogene Therapeutics, Inc. for the year ended December 31, 2023.
/s/ Ernst & Young LLP
San Mateo, California
March 14, 2024